MKI67 and B-cell chronic lymphocytic leukemia: CLL cells persisted in some recipients for as long as 75 days post splenocyte infusion with ki67+ cells (>70%), which were CD19+, still seen, reflecting ongoing proliferation in the CLL cells in this locale.